Showing results (81-90 of 107) with videos related to
Sort By:
Pageof 11
Journal of Cancer Education : the Official Journal of the American Association for Cancer Education|November 5, 1997
Improving physician-patient communication in cancer care: outcome of a workshop for oncologistsW F Baile, R Lenzi, A P Kudelka, et al.Laboratory Investigation; a Journal of Technical Methods and Pathology|March 1, 1992
Histogenesis of bile duct-like cells proliferating during ethionine hepatocarcinogenesis. Evidence for a biliary epithelial nature of oval cellsR Lenzi, M H Liu, F Tarsetti, et al.International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|September 1, 1995
Phase II study of prolonged oral etoposide in refractory ovarian cancerJ.J. Kavanagh, D. Tresukosol, C. Gonzalez De Leon, et al.Clinical and Experimental Immunology|July 2, 1998
Differential expression of cytokine transcripts in human epithelial ovarian carcinoma by solid tumour specimens, peritoneal exudate cells containing tumour, tumour-infiltrating lymphocyte (TIL)-derived T cell lines and established tumour cell linesM A Nash, R Lenzi, C L Edwards, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 8, 2001
Phase I trial of gemcitabine combined with radiation for the treatment of locally advanced pancreatic adenocarcinomaR A Wolff, D B Evans, D M Gravel, et al.Investigational New Drugs|June 1, 2000
Current approaches and future strategies for pancreatic carcinomaR A Wolff, P Chiao, R Lenzi, et al.Cancer|August 27, 1999
Communication skills training in oncology. Description and preliminary outcomes of workshops on breaking bad news and managing patient reactions to illnessW F Baile, A P Kudelka, E A Beale, et al.Journal of Endocrinological Investigation|December 2, 2022
Transition in endocrinology: predictors of drop-out of a heterogeneous population on a long-term follow-upF Prodam, M Caputo, M Romanisio, et al.International Journal of Gastrointestinal Cancer|January 24, 2003
Phase I study of concomitant gemcitabine and IMRT for patients with unresectable adenocarcinoma of the pancreatic headC H Crane, J A Antolak, I I Rosen, et al.International Journal of Gastrointestinal Cancer|May 20, 2003
Toxicity and Efficacy of Concurrent Gemcitabine and Radiotherapy for Locally Advanced Pancreatic CancerChristopher Crane, N Janjan, D Evans, et al.Pageof 11